@article{d4eec44d31d8491e90a7bd21dda03a7f,
title = "Using omega-3 fatty acids in the practice of clinical lipidology",
author = "Brown, {W. Virgil} and Harold Bays and William Harris and Michael Miller",
note = "Funding Information: Dr. Bays has received consulting fees from Amarin Corporation, AstraZeneca, Daiichi Sankyo, GlaxoSmithKline, Merck & Co., and Zeomedex. Dr. Bays has received honoraria related to speaking from Amarin Corporation, AstraZeneca, Daiichi Sankyo, GlaxoSmithKline, Merck & Co., and Zeomedex. Dr. Bays has received grants from Amarin Corporation, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, California Raisin Board, Cargill Incorporated, Daiichi Sankyo, Eli Lilly and Co, Esperion, Essentialis, Forest Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Nicox, Novo Nordisk, Omthera Pharmaceuticals, Orexigen Therapeutics, Pfizer Inc., Pozen, Proctor & Gamble Inc., Schering Plough, Shionogi, Stratum Nutrition, Takeda Pharmaceuticals, Trygg Pharmaceuticals, Trygg Pharmaceuticals, and TWI Bio. Dr. Harris has received consulting fees from Acasti Pharmaceuticals and Omthera Pharmaceuticals. Dr. Harris has received honoraria related to speaking from GlaxoSmithKline. Dr. Harris has received salary from Health Diagnostics Laboratory Inc. Dr. Harris has ownership interest in OmegaQuant LLC. Dr. Miller has received consulting fees from Amarin Corporation.",
year = "2011",
doi = "10.1016/j.jacl.2011.09.006",
language = "English (US)",
volume = "5",
pages = "424--433",
journal = "Journal of clinical lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "6",
}